ArticleScientific reports2021

Tocilizumab reduces COVID-19 mortality and pathology in a dose and timing-dependent fashion: a multi-centric study.

Alejandro Durán-Méndez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.